Dr. Nightingale now offers Ketamine Assisted Therapy in association with Journey Clinical.
Dr. offers a therapeutic modality called Ketamine-Assisted Psychotherapy (KAP) in partnership with an organization called Journey Clinical. Ketamine-Assisted Psychotherapy (KAP) is a holistic modality in which ketamine is used as a complement to psychotherapy to help eligible patients experience more frequent breakthroughs and sustained improvement in symptoms. Dr. Nightingale provides the psychotherapy portion of the experience, while Journey Clinical’s medical team supports you on all medical aspects. This includes determining eligibility, developing a custom treatment plan, prescribing the medicine and monitoring outcomes. Below is more information about KAP to help you navigate if it may be a good fit for you.
What is Ketamine? Ketamine is a legal, safe and effective medicine used to treat a variety of mental health conditions, including depression, anxiety and PTSD. Ketamine has rapidlyacting antidepressant and mood-enhancing effects, which can begin to take effect within 1-2 hrs. after treatment. It works by blocking the brain’s NMDA receptors as well as by stimulating AMPA receptors, which are thought to help form new synaptic connections and boost neural circuits that regulate stress and mood. Ketamine has also been shown to enhance overall neuroplasticity for lasting symptom improvement. Ketamine can be administered in a variety of ways, including IV infusion, intramuscular injection, via nasal spray and using sublingual lozenges. In my work with Journey Clinical we only use the sublingual lozenge form.
How Does Ketamine Feel? The effects of ketamine, which most patients find pleasant, last for approximately 45 minutes. These effects can make you feel “far from” your body, and facilitate shifts in perception that can often feel expansive in nature. Your motor and verbal abilities will be reduced, so you’ll be lying down in a comfortable position during the experience. Once these effects subside, we’ll spend the remainder of our appointment giving you space to process and discuss your experience. While it may feel hard to articulate what happens during the experience, patients feel like the insights gained are clear
How does Ketamine-Assisted Psychotherapy work?
Speak with Dr. Nightingale about your interest in KAP.
Complete your initial consultation with Journey Clinical prescriber, eligibility check and ketamine prescription Patient in therapy with member psychotherapist
Attend preparation sessions together to align on the process and set intentions for the KAP dosing session
KAP dosing session: You will self-administer your ketamine lozenge at Dr. Nightingale’s office or remotely Integration sessions to review the memories, thoughts & insights that arise during your dosing session
Follow-up consultations with Journey Clinical prescriber with prescription refills if eligible.
What is the Cost of Treatment? Ketamine-Assisted Psychotherapy is an affordable, accessible modality. Although the medical intake and follow ups are not covered by insurance, they are eligible for out-of-network reimbursement. Ketamine-Assisted Psychotherapy
• Dr. Nightingale’s hourly rate for preparation sessions, dosing sessions and integrations sessions is $250.00
• Initial medical consultation with Journey Clinical: $250
• Cost of medication: $85 (enough for 2 sessions)
Ongoing treatment
• Follow-up medical consultation with Journey Clinical: $150 (at least 1X per quarter)
• Cost of medication: $145 (enough for up to 6 sessions)
What is Journey Clinical? Journey Clinical is a platform for licensed psychotherapists to incorporate science-based psychedelic therapies in their practice safely and effectively, starting with Ketamine Assisted Psychotherapy (KAP). Journey Clinical’s in-house medical team takes on patient eligibility, prescriptions and outcome monitoring, while Dr. Nightingale takes on the therapy. Their collaborative care model is designed to deliver personalized treatment plans to meet your individual needs and improve long-term outcomes.